BOOKS AND ARTICLES ON STUDY DESIGN

A. GENERAL REVIEWS
B. MODELING
C. ECONOMIC EVALUATION ALONGSIDE CLINICAL TRIALS

A. GENERAL REVIEWS
 
B. MODELING 
  1. GENERAL MODELING ISSUES
 
  1. Grieve R, Hutton J, Green C. Selecting methods for the prediction of future events in cost-effectiveness models: a decision-framework and example from the cardiovascular field. Health Policy 2003; 64:311-24.
    Review
     
  2. Diehr P, Yanez D, Ash A, et al. “Methods for Analyzing Health Care Utilization and Costs.” Annual Review of Public Health. 1999;20:125-44.
  2. DECISION ANALYSIS MODELS
 
  1. Weinstein M and Fineberg H.: Clinical Decision Analysism WB Saunders, Phildadelphia 1980.
    Review
     
  2. TreeAge Healthcare User’s Manual
    www.treeage.com
    Review
     
  3. Caro JJ. “Pharmacoeconomic Analyses Using Discrete Event Simulation.” Pharmacoeconomics. 2005;23(4):323-32.
     
  4. Detsky AS, Naglie G, Krahn MD, et al. “Primer on medical decision analysis: Part 1—Getting started.” Med Decis Making. Apr-Jun 1997;17(2):123-5.
     
  5. Detsky AS, Naglie G, Krahn MD, et al. “Primer on medical decision analysis: Part 2—Building a tree.” Med Decis Making. Apr-Jun 1997;17(2):126-35.
    Detsky AS, Naglie G, Krahn MD, et al. “Primer on medical decision analysis: Part 2—Building a tree.” Med Decis Making. Apr-Jun 1997;17(2):126-35.
     
  6. Krahn MD, Naglie G, Naimark D, et al. “Primer on medical decision analysis: Part 4—Analyzing the model and interpreting the results.” Med Decis Making. Apr-Jun 1997;17(2):142-51.
     
  7. Naglie G, Krahn MD, Naimark D, et al. “Primer on medical decision analysis: Part 3—Estimating probabilities and utilities.” Med Decis Making. Apr-Jun 1997;17(2):136-41.
  3. TRANSITION STATE MODELS (Markov models)
 
  1. Naimark D, Krahn MD, Naglie G, Redelmeier DA, Detsky AS. Primer on Medical Decision Analysis: Part 5 – Working with Markov Processes.
    Medical Decision Making 1997; 17(2):152-9.

    PMID: 9107610 [PubMed - indexed for MEDLINE]
    Review
     
  2. Sonnenberg FA, Beck JR. Markov models in Medical Decision Making: A Practical Guide.
    Medical Decision Making 1993;13(4)322-38.

    PMID: 8246705 [PubMed - indexed for MEDLINE]
    Review
     
  3. Beck JR, Pauker SG. The Markov Process in Medical Prognosis.
    Medical Decision Making 1983;3(4):419-58.

    PMID: 6668990 [PubMed - indexed for MEDLINE]
    Review
     
  4. Briggs A, Schulpher M. “An Introduction to Markov Modeling for Economic Evaluation.” Pharmacoeconomics. Apr 1998;13(4):397-409.
     
  5. Sonnenberg FA, Beck JR. “Markov Models in Medical Decision Making: A Practical guide,” Med Decis Making. Oct-Dec 1993;13(4):322-38.

TOP

  4. PROBABILISTIC MODELS
 
  1. Critchfield GC, Willard KE, Connelly DP. Probabilistic Sensitivity Analysis Methods for General Decision Models. Comput Biomed Res. 1986;19(3)254-65.

    PMID: 3709122 [PubMed - indexed for MEDLINE]
    Review
     
  2. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic Sensitivity Analysis Using Monte Carlo Simulation: A Practical Approach. Medical Decision Making 1985;5(2):157-77.

    PMID: 3831638 [PubMed - indexed for MEDLINE]
    Review

C. ECONOMIC EVALUATION ALONGSIDE CLINICAL TRIALS (”piggy-back”)
 
  1. O’Sullivan AK, Thompson D, Drummond MF. Collection of Health-Economic Data Alongside Clinical Trials: Is There a Future for Piggyback Evaluations? Value in Health 2005;8(1):67-79.
    Review
 

TOP


Educator's Tool Kit main page
 

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2010 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.
 
Website design by Eagle Systems USA, Inc.